Order Article Reprints

Mutoh Y, Umemura T, Nishikawa T, Kondo K, Nishina Y, Soejima K, Noguchi Y, Bando T, Ota S, Shimahara T, et al. Real-World Experience of the Comparative Effectiveness and Safety of Molnupiravir and Nirmatrelvir/Ritonavir in High-Risk Patients with COVID-19 in a Community Setting. Viruses. 2023; 15(3):811. https://doi.org/10.3390/v15030811

Mutoh, Yoshikazu, Takumi Umemura, Takeshi Nishikawa, Kaho Kondo, Yuta Nishina, Kazuaki Soejima, Yoichiro Noguchi, Tomohiro Bando, Sho Ota, Tatsuki Shimahara, and et al. 2023. "Real-World Experience of the Comparative Effectiveness and Safety of Molnupiravir and Nirmatrelvir/Ritonavir in High-Risk Patients with COVID-19 in a Community Setting" Viruses 15, no. 3: 811. https://doi.org/10.3390/v15030811

Mutoh, Y., Umemura, T., Nishikawa, T., Kondo, K., Nishina, Y., Soejima, K., Noguchi, Y., Bando, T., Ota, S., Shimahara, T., Hirota, S., Hagimoto, S., Takei, R., Fukihara, J., Sasano, H., Yamano, Y., Yokoyama, T., Kataoka, K., Matsuda, T., ... Kondoh, Y. (2023). Real-World Experience of the Comparative Effectiveness and Safety of Molnupiravir and Nirmatrelvir/Ritonavir in High-Risk Patients with COVID-19 in a Community Setting. Viruses, 15(3), 811. https://doi.org/10.3390/v15030811